This App has been developed as a resource to assist Australian patients with severe allergic asthma who have been prescribed Xolair® (omalizumab) to remind them of their ongoing appointments, and for their fortnightly or monthly injections advised by their specialists.
The application requires a password which can be obtained from the patients’ healthcare professional.
Disclaimer: This App is not a medical device. This App is intended for use as a personal reminder tool only.
This App is published by Novartis Pharmaceuticals Australia Pty Limited and is intended for an Australian audience. CORP0292 December 2015.